If the recommendation is accepted by the European Commission, Moderna's mCombriax vaccine will be available for adults 50 and older throughout the European Union. Continue Reading »

Levels of RSV also remain high in many areas of the US, while COVID-19 activity is waning in most of the country. Continue Reading »

Both geographic location and work setting are tied to insomnia risk.  Continue Reading »

A single dose of mRNA-1073 elicited durable immune responses through 6 months against all vaccine-matched influenza and SARS-CoV-2 strains. Continue Reading »

A long-term study finds that most college students bounced back emotionally after the COVID-19 pandemic, with improved psychological functioning, less loneliness, and more satisfaction with their lives.  Continue Reading »

Adults living with HIV are 29% more likely to have long-term COVID symptoms, study suggests. Continue Reading »

So far this season, the CDC estimates that there have been at least 24 million flu-related illnesses, 310,000 hospitalizations, and 20,000 deaths.  Continue Reading »

Adults with long COVID had an 86% higher risk of depression and a 60% higher risk of anxiety. Continue Reading »

Full vaccination and a booster dose reduced the risk of preeclampsia by 15% and 33%, respectively, the authors estimate. Continue Reading »

Children with the condition are also more likely to have severe infections, the study suggests. Continue Reading »

Positive samples were significantly more common in the emergency department than in intensive care. Continue Reading »

Hospitalized and non-hospitalized COVID patients were 41% and 33%, respectively, more likely to be diagnosed as having apnea than uninfected controls.  Continue Reading »

Elevated risk was not seen among people who were partially or fully vaccinated. Continue Reading »

Flu, respiratory syncytial virus, and COVID-19 levels still elevated in some parts of the country. Continue Reading »

Conversely, anxiety and depression were seen less frequently. Continue Reading »

The discovery will allow vaccine developers to avert the disorder by adjusting the adenovirus protein in the vaccines, the authors say. Continue Reading »

No similar link found between infection and impaired fertility in females, new review suggests.  Continue Reading »

The perceived safety of the MMR vaccine is now 83% (down from 86%). Continue Reading »

A new study finds no increase in autism rates in babies born to mothers who received COVID-19 vaccines just before or during pregnancy, compared with children of unvaccinated moms. Continue Reading »

Relative to people of healthy weight, those with class 3 obesity were 3 times more likely to be hospitalized for or die of infection.  Continue Reading »

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 21 - 27 February 2026 and includes updates on respiratory virus epidemiology in the EU/EEA, mass gathering monitoring, chikungunya, cholera, and swine flu. Continue Reading »

Respiratory virus trends across the EU/EEA show early signs of decline. RSV activity remains high, with young children most affected. Influenza circulation remains widespread, but continues to decrease in most countries. SARS CoV 2 activity remains low. Continue Reading »

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 7 - 13 February 2026 and includes updates on respiratory virus epidemiology in the EU/EEA, mass gathering monitoring, avian influenza, and mpox. Continue Reading »

Respiratory virus activity remains elevated across the EU/EEA: influenza transmission is still widespread but decreasing, and RSV levels remain high, while SARS CoV 2 circulation remains low. Continue Reading »

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 7 - 13 February 2026 and includes updates on respiratory virus epidemiology in the EU/EEA, mass gathering monitoring, avian influenza, chikungunya, dengue, Nipah virus disease, and ... Continue Reading »

Respiratory virus circulation is elevated across the EU/EEA: the circulation of influenza viruses is still high and RSV circulation is elevated and increasing. SARS-CoV-2 circulation continues to be low. Continue Reading »

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 31 January - 6 February 2026 and includes updates on respiratory virus epidemiology in the EU/EEA, SARS-CoV-2 variant classification, Bacillus cereus toxin in infant formula, mass ... Continue Reading »

Respiratory virus circulation is elevated across the EU/EEA. The circulation of influenza viruses remains high with early signs of a new increase, RSV circulation is elevated and increasing, and SARS-CoV-2 circulation remains at low levels. Continue Reading »

The Winter Olympics will kick off on 6 February 2026 and run until 22 February, while the Paralympics will take place between 6 and 15 March. Continue Reading »

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 24-30 January 2026 and includes updates on respiratory virus epidemiology in the EU/EEA, Marburg virus disease, cholera, avian influenza, bacillus in infant formula, and nipah virus disease. Continue Reading »